Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III trial of irofulven in pancreatic cancer proceeds on schedule

Feb. 9, 2001

Demegen to expand cancer research

Feb. 9, 2001

Novel vaccine approach warrants further evaluation in pancreatic cancer

Feb. 9, 2001

Curvularol: a naturally produced cell cycle inhibitor

Feb. 9, 2001

WHI-P233, a new cytotoxic melamine derivative

Feb. 8, 2001

Progen concludes phase Ib evaluation of PI-88

Feb. 8, 2001

Novel fluoroindolocarbazoles formed in rebeccamycin-producing microorganism

Feb. 8, 2001

Isolation, structure determination and cytotoxic activity of AJI-9561

Feb. 8, 2001

Novel DNA crosslinker with potential in the treatment of cisplatin-resistant ovarian cancer

Feb. 8, 2001

Phase II study examines IMC-C225 in combination with other agents for NSCLC

Feb. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...